1. Assessment of community-level effects of intermittent preventive treatment for malaria in schoolchildren in Jinja, Uganda (START-IPT trial): a cluster-randomised trial 
Prof Sarah G Staedke, PhD, Catherine Maiteki-Sebuguzi, MSc, Andrea M Rehman, PhD, Simon P Kigozi, MSc, Samuel Gonahasa, MBChB, Jaffer Okiring, MSc, Prof Steve W Lindsay, PhD, Prof Moses R Kamya, PhD, Clare I R Chandler, PhD, Prof Grant Dorsey, PhD, Prof Chris Drakeley, PhD 
The Lancet Global Health 
Volume 6, Issue 6, Pages e668-e679 (June 2018)
DOI: /S X(18)
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY 4.0 license Terms and Conditions

2. Figure 1 Map of study area
The study included 84 clusters, each including one primary school and the closest available 100 surrounding households. IPT=intermittent preventive treatment.
The Lancet Global Health 2018 6, e668-e679DOI: ( /S X(18) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY 4.0 license Terms and Conditions

3. Figure 2
Trial profile
IPT=intermittent preventive treatment. DP=dihydroartemisinin-piperaquine. AL=artemether-lumefantrine. *One household was excluded and replaced with a newly recruited household.
The Lancet Global Health 2018 6, e668-e679DOI: ( /S X(18) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY 4.0 license Terms and Conditions